Previous studies suggested that the knockdown of PIF1 inhibited the growth of human NSCLC cells and promoted cell apoptosis and could serve as a potential therapeutic target for treating lung cancer. This evidence concerns the gene PIF1 and non-small cell lung carcinoma.